drugset / Trial / NCT04804423

Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth

NCT04804423

Phase 2/3 Completed 30 enrolled University Medicine Greifswald SDI Limited · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This observational cohort study aims to evaluate the short-term (3 months) efficacy of the standard fluoride therapy in the German National Health System for managing hypersensitive carious lesions in primary teeth (fluoride varnish application), and further compare it to a different fluoride therapy utilizing a silver-containing fluoride agent combined with potassium iodide solution.

Timeline

Start
2020-01-13
Primary completion
2021-03-31
Completion
2021-04-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Silver Fluoride Unknown 38 % Topical
Subject potassium iodide Unknown Topical
Comparator sodium fluoride Unknown 22600 ppm Topical